Beyond Stargate's big players, a growing number of innovators have been revolutionizing healthcare by making recent ...

Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report ...

CHICAGO—Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. (NASDAQ:TEM), has recently sold a significant portion of his holdings in the company. According to a filing with the Securities and ...

Experts say Investors may be valuing AI companies too generously if health systems can’t justify the costs of these tools.

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

Eric Lefkofsky, founder and CEO of Tempus AI, explains the impact of acquiring Ambry, a genetic testing company, which ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Just 10 days after Pelosi’s AI stock acquisition, the chief executive officer (CEO) of the company dumped $62 million worth ...

Eric Lefkofsky, CEO and Chairman of Tempus AI, Inc. (NASDAQ:TEM), recently sold shares worth approximately $7,045,334, according to an SEC filing. The transactions occurred on... Ryan Fukushima, Chief ...

In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares beginning on January 22, totaling about $62M. On January 22, Lefkofsky sold ...